RAP 0.00% 20.5¢ resapp health limited

The Breath Easy Study, page-19

  1. rkb
    323 Posts.
    lightbulb Created with Sketch. 51
    Have been thinking about RAP a bit lately and trying to evaluate its worth, not so much its share price, but it's worth to the medical profession and to society. As I understand the App its value is in its diagnostic capability. Earlier and more accurate diagnosis of symptoms. Whilst this will lead to earlier and more targetted treatment I just wanted to be sure that the App is not, in itself, a cure of any disability. I guess, where I am going with these thoughts is whether the widespread adoption of the App might lead to reforms in the treatment of various conditions.
    My apologies if I am just wasting your time.
    Last edited by rkb: 16/05/19
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.